A model on the large scale use of convalescent plasma to treat patients with severe symptoms

DOI10.1007/978-3-030-85053-1_6MaRDI QIDQ2089575zbMATH OpenOpenAlexFDO

Authors Xi Huo

Publication date 22 October 2022

Full work available at URL https://doi.org/10.1007/978-3-030-85053-1_6

Mathematics Subject Classification ID

Epidemiology (92D30)

Recommendations

• Simulation study about large-scale use of convalescent plasma therapy for the treatment of COVID-19 patients with critical symptoms
• Modelling the impact of plasma therapy and immunotherapy for recovery of COVID-19 infected individuals
• A multiclass, multiproduct covid-19 convalescent plasma donor equilibrium model
• Optimal control of vaccination and plasma transfusion with potential usefulness for Covid-19
• Effective lockdown and plasma therapy for COVID-19
• Models for plasma kinetics during simultaneous therapeutic plasma exchange and extracorporeal membrane oxygenation
• Treatment-donation-stockpile dynamics in Ebola convalescent blood transfusion therapy
• Data-driven fair resource allocation for novel emerging epidemics: a COVID-19 Convalescent Plasma case study
• A model for SARS-CoV-2 infection with treatment
• scientific article; zbMATH DE number 1749973

Cites work

• Treatment-donation-stockpile dynamics in Ebola convalescent blood transfusion therapy

Cited in

(3)

• A multiclass, multiproduct covid-19 convalescent plasma donor equilibrium model
• Treatment-donation-stockpile dynamics in Ebola convalescent blood transfusion therapy
• Simulation study about large-scale use of convalescent plasma therapy for the treatment of COVID-19 patients with critical symptoms

This page was built for publication: A model on the large scale use of convalescent plasma to treat patients with severe symptoms

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2089575)